Aclaris Therapeutics Inc (ACRS)

Deferred Revenue

$3.98M

Quarterly · Period ending: · USD

ACRS logo

ACRS Deferred Revenue

Latest reported$3.94M
ACRS FY Deferred Revenue ($0.00 → $3.94M)
High-resolution chart · PNG

ACRS deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
3,943,000
3,890,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.